These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15083155)

  • 1. Interplay between mycobacteria and host signalling pathways.
    Koul A; Herget T; Klebl B; Ullrich A
    Nat Rev Microbiol; 2004 Mar; 2(3):189-202. PubMed ID: 15083155
    [No Abstract]   [Full Text] [Related]  

  • 2. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages.
    Nguyen L; Pieters J
    Trends Cell Biol; 2005 May; 15(5):269-76. PubMed ID: 15866031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of pathogenic mycobacteria with the host immune system.
    Houben EN; Nguyen L; Pieters J
    Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin.
    Jayachandran R; Sundaramurthy V; Combaluzier B; Mueller P; Korf H; Huygen K; Miyazaki T; Albrecht I; Massner J; Pieters J
    Cell; 2007 Jul; 130(1):37-50. PubMed ID: 17632055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway.
    Bohsali A; Abdalla H; Velmurugan K; Briken V
    BMC Microbiol; 2010 Sep; 10():237. PubMed ID: 20831789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.
    Jo EK; Yang CS; Choi CH; Harding CV
    Cell Microbiol; 2007 May; 9(5):1087-98. PubMed ID: 17359235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The secret lives of the pathogenic mycobacteria.
    Cosma CL; Sherman DR; Ramakrishnan L
    Annu Rev Microbiol; 2003; 57():641-76. PubMed ID: 14527294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages.
    Walburger A; Koul A; Ferrari G; Nguyen L; Prescianotto-Baschong C; Huygen K; Klebl B; Thompson C; Bacher G; Pieters J
    Science; 2004 Jun; 304(5678):1800-4. PubMed ID: 15155913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages.
    Yang CS; Song CH; Lee JS; Jung SB; Oh JH; Park J; Kim HJ; Park JK; Paik TH; Jo EK
    Cell Microbiol; 2006 Jul; 8(7):1158-71. PubMed ID: 16819968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Battle for survival: interplay between pathogenic mycobacteria and the host immune system.
    Nguyen L; Pieters J
    Discov Med; 2006 Apr; 6(32):82-6. PubMed ID: 17234131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages.
    de Chastellier C
    Immunobiology; 2009; 214(7):526-42. PubMed ID: 19261352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiology. Chemical warfare and mycobacterial defense.
    Pieters J; Ploegh H
    Science; 2003 Dec; 302(5652):1900-2. PubMed ID: 14671281
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of mycobacterial persistence in tuberculosis.
    Kusner DJ
    Clin Immunol; 2005 Mar; 114(3):239-47. PubMed ID: 15721834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis modulators of the macrophage's cellular events.
    Poirier V; Av-Gay Y
    Microbes Infect; 2012 Nov; 14(13):1211-9. PubMed ID: 22841679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.
    Briken V; Porcelli SA; Besra GS; Kremer L
    Mol Microbiol; 2004 Jul; 53(2):391-403. PubMed ID: 15228522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell-cell interactions during formation and reactivation of "nonculturable" mycobacteria].
    Salina EG; Vostroknutova GN; Shleeva MO; Kaprel'iants AS
    Mikrobiologiia; 2006; 75(4):502-8. PubMed ID: 17025176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
    Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
    Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression.
    Guenin-Macé L; Siméone R; Demangel C
    Transbound Emerg Dis; 2009 Aug; 56(6-7):255-68. PubMed ID: 19486312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.